Browsing Tag
AxisBiotix
2 posts
SkinBioTherapeutics (LSE: SBTX) is growing again, but will cash last long enough?
SkinBioTherapeutics is growing revenue, but cash and credibility remain tight. New FY2026 guidance will decide whether SBTX can rerate.
SkinBioTherapeutics signs exclusive Superdrug deal and raises £4.7m to fund AxisBiotix rollout
SkinBioTherapeutics secures exclusive Superdrug partnership, raises £4.7m, and earns US psoriasis recognition—discover what this means for investors and market expansion.